Company page
Hanall Biopharma Co., Ltd.
Hanall Biopharma Co., Ltd. is a public company based in Korea, trading under the ticker 009420. The company has a market capitalization of approximately 1.8 billion USD. Hanall Biopharma focuses on developing innovative biopharmaceuticals to address unmet medical needs.
- Ticker
- 009420:KRX
- Asset type
- Stock
- Market cap
- $1.80B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW